FRA:GA6
Delisted

Gaia Stock Signals

etoro logo Buy GA6
*Your capital is at risk
2.34€
+0 (+0%)
At Close: Dec 21, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Gaia, Inc.

General

Signal Type Signal Value Data
Score 0.000 492 days ( 64.00 %
Last Price 2.34€ 0 %
Performance History
7 Days
2.34€ 2.34€
0%
30 Days
2.34€ 2.34€
0%
12 Mos
2.32€ 2.34€
0.86%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low 2.34€ - 2.34€
Trend - 3 mos -0.431 % High Width: 2.56 %
Pred. range - 3 mos 2.32€ - 2.38€ Low -0.85 % - 1.69 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Sep 27, 2023 - 62 days
RSI Short Pivot Signal Buy Very Low Oct 12, 2023 - 51 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Oct 24, 2023 - 43 days
Short/Long MA 3 mos Sell Medium Oct 24, 2023 - 43 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 51.18
Signal Type Signal Value Importance Data
Trend - 12 mos -16.69 % Very High Width: 145.72 %
Pred. range - 12 mos 1.07€ - 2.64€ High -54.14 % - 12.68 %
Short MA 12 mos Sell Very High Oct 04, 2023 - 57 days
Long MA 12 mos Buy Very High Sep 07, 2023 - 76 days
Short/Long MA 12 mos Buy Very High Sep 19, 2023 - 68 days
Pivot Long Buy Low Sep 21, 2023 - 66 days
RSI Long Pivot Signal Buy Low Oct 23, 2023 - 44 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT GAIA, INC.
Gaia
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE